Corvus Pharmaceuticals (CRVS)
(Delayed Data from NSDQ)
$5.91 USD
+0.30 (5.35%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $5.91 0.00 (0.00%) 6:26 PM ET
3-Hold of 5 3
C Value B Growth C Momentum C VGM
Brokerage Reports
Corvus Pharmaceuticals, Inc. [CRVS]
Reports for Purchase
Showing records 141 - 154 ( 154 total )
Company: Corvus Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Biotechnology -ESMO 2018 Abstract Roundup for Covered Companies
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Corvus Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Corvus Pharmaceuticals, Inc.
Industry: Unclassified
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Corvus Pharmaceuticals, Inc.
Industry: Unclassified
Company: Corvus Pharmaceuticals, Inc.
Industry: Unclassified
Company: Corvus Pharmaceuticals, Inc.
Industry: Unclassified
Q4 Financials; Second Adenosine Program CD73 Antibody Moves in to Clinic
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Corvus Pharmaceuticals, Inc.
Industry: Unclassified
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Corvus Pharmaceuticals, Inc.
Industry: Unclassified
SITC Update Highlights Durability in RCC, Potential Biomarker Utility
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Corvus Pharmaceuticals, Inc.
Industry: Unclassified
Biotechnology - SITC Meeting Preview for Covered Companies
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Corvus Pharmaceuticals, Inc.
Industry: Unclassified
Q3 Financials; CPI-444 Data To be Updated at SITC
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Corvus Pharmaceuticals, Inc.
Industry: Unclassified
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Corvus Pharmaceuticals, Inc.
Industry: Unclassified
HEALTHCARE - 2017 PacGrow Healthcare Conference: Day 2 Recap
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Corvus Pharmaceuticals, Inc.
Industry: Unclassified
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Corvus Pharmaceuticals, Inc.
Industry: Unclassified
Initiating with an OUTPERFORM and $26 PT: Active Agents Antagonizing Adenosine
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R